Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129


High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana.

Shapiro RL, Souda S, Parekh N, Binda K, Kayembe M, Lockman S, Svab P, Babitseng O, Powis K, Jimbo W, Creek T, Makhema J, Essex M, Roberts DJ.

PLoS One. 2012;7(2):e31580. doi: 10.1371/journal.pone.0031580. Epub 2012 Feb 22.


Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S, Powis K, Dryden-Peterson S, Creek T, Jimbo W, Madidimalo T, Makhema J, Essex M, Shapiro RL.

J Infect Dis. 2012 Dec 1;206(11):1695-705. doi: 10.1093/infdis/jis553. Epub 2012 Oct 12.


Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.

AIDS. 2008 Sep 12;22(14):1815-20. doi: 10.1097/QAD.0b013e32830b8ab9.


Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.

Joseph O, Biodun O, Michael E.

J Coll Physicians Surg Pak. 2011 Jun;21(6):356-9. doi: 07.2011/JCPSP.356359.


High viral load and elevated angiogenic markers associated with increased risk of preeclampsia among women initiating highly active antiretroviral therapy in pregnancy in the Mma Bana study, Botswana.

Powis KM, McElrath TF, Hughes MD, Ogwu A, Souda S, Datwyler SA, von Widenfelt E, Moyo S, Nádas M, Makhema J, Machakaire E, Lockman S, Essex M, Shapiro RL.

J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):517-24. doi: 10.1097/QAI.0b013e318286d77e.


The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants.

Frederick T, Homans J, Spencer L, Kramer F, Stek A, Operskalski E, Kovacs A.

Clin Infect Dis. 2012 Sep;55(6):877-84. doi: 10.1093/cid/cis535. Epub 2012 Jun 6.


Antiretroviral treatment initiation among HIV-infected pregnant women with low CD4(+) cell counts in Gaborone, Botswana.

Chen JY, Ogwu AC, Svab P, Lockman S, Moffat HJ, Gaolathe T, Moilwa S, Størdal K, Dryden-Peterson S, Moffat C, Makhema J, Essex M, Shapiro RL.

J Acquir Immune Defic Syndr. 2010 May 1;54(1):102-6. doi: 10.1097/QAI.0b013e3181c080bf.


Pregnant women's access to PMTCT and ART services in South Africa and implications for universal antiretroviral treatment.

Hussain A, Moodley D, Naidoo S, Esterhuizen TM.

PLoS One. 2011;6(12):e27907. doi: 10.1371/journal.pone.0027907. Epub 2011 Dec 5.


Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, Hayani K, Handelsman E, Smeriglio V, Hoff R, Blattner W; Women and Infants' Transmission Study Group.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):484-94.


Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.

PLoS Med. 2007 Aug;4(8):e257.


Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland.

Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA.

AIDS. 2007 May 11;21(8):1019-26.


[Mode of delivery of HIV-infected women: a retrospective study of 358 pregnancies followed in the same hospital between 2000 and 2004].

Rodrigues A, Faucher P, Batallan A, Allal L, Legac S, Matheron S, Madelenat P.

Gynecol Obstet Fertil. 2006 Apr;34(4):304-11. Epub 2006 Mar 29. French.


The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.

McCabe CJ, Goldie SJ, Fisman DN.

PLoS One. 2010 Apr 13;5(4):e10154. doi: 10.1371/journal.pone.0010154.


Antiretroviral treatment during pregnancy.

Keiser O, Gayet-Ageron A, Rudin C, Brinkhof MW, Gremlich E, Wunder D, Drack G, Hirschel B, de Tejada BM; Swiss HIV Cohort Study (SHCS); Swiss Mother & Child HIV Cohort Study (MoCHiV).

AIDS. 2008 Nov 12;22(17):2323-30. doi: 10.1097/QAD.0b013e3283189bf1.


Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.

Kouanda S, Tougri H, Cisse M, Simpore J, Pietra V, Doulougou B, Ouedraogo G, Ouedraogo CM, Soudre R, Sondo B.

AIDS Care. 2010 Jul;22(7):843-50. doi: 10.1080/09540120903499204.


The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009.

Namukwaya Z, Mudiope P, Kekitiinwa A, Musoke P, Matovu J, Kayma S, Salmond W, Bitarakwate E, Mubiru M, Maganda A, Galla M, Byamugisha J, Fowler MG.

J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):69-75. doi: 10.1097/QAI.0b013e3181fdb4a8.


[Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].

Tempelman C, Timmermans S, Godfried MH, Dieleman JP, Boer K, van der Ende ME.

Ned Tijdschr Geneeskd. 2004 Oct 9;148(41):2021-5. Dutch.


Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk.

Shapiro RL, Ndung'u T, Lockman S, Smeaton LM, Thior I, Wester C, Stevens L, Sebetso G, Gaseitsiwe S, Peter T, Essex M.

J Infect Dis. 2005 Sep 1;192(5):713-9. Epub 2005 Jul 27.


Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.

Stinson K, Boulle A, Coetzee D, Abrams EJ, Myer L.

Trop Med Int Health. 2010 Jul;15(7):825-32. doi: 10.1111/j.1365-3156.2010.02538.x. Epub 2010 May 18.


No relation between in-utero exposure to HAART and intrauterine growth retardation.

Briand N, Mandelbrot L, Le Chenadec J, Tubiana R, Teglas JP, Faye A, Dollfus C, Rouzioux C, Blanche S, Warszawski J; ANRS French Perinatal Cohort.

AIDS. 2009 Jun 19;23(10):1235-43. doi: 10.1097/QAD.0b013e32832be0df.

Items per page

Supplemental Content

Write to the Help Desk